Comparison of remission criteria in a tumour necrosis factor inhibitor treated rheumatoid arthritis longitudinal cohort: patient global health is a confounder

INTRODUCTION: Our objectives were to assess the frequency and sustainability of American College of Rheumatology (ACR)/European League against Rheumatism (EULAR) and Disease Activity Score (DAS)28(4v)–C-reactive protein (CRP) remission 12 months after the initiation of tumour necrosis factor inhibit...

Descripción completa

Detalles Bibliográficos
Autores principales: Balogh, Emese, Madruga Dias, Joao, Orr, Carl, Mullan, Ronan, Harty, Len, FitzGerald, Oliver, Gallagher, Phil, Molloy, Miriam, O’Flynn, Eileen, Kelly, Alexia, Minnock, Patricia, O’Neill, Madeline, Moore, Louise, Murray, Mairead, Fearon, Ursula, Veale, Douglas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978469/
https://www.ncbi.nlm.nih.gov/pubmed/24365061
http://dx.doi.org/10.1186/ar4421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978469/
https://www.ncbi.nlm.nih.gov/pubmed/24365061
http://dx.doi.org/10.1186/ar4421

Ejemplares similares